home / stock / thtx / thtx articles

THTX Articles, Theratechnologies Inc.

Stock Information
Company Name: Theratechnologies Inc.
Stock Symbol: THTX
Market: NYSE
Website: theratech.com
Menu
THTX THTX Quote THTX Short THTX News THTX Articles THTX Message Board
Get THTX Alerts

News, Short Squeeze, Breakout and More Instantly...
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update | Benzinga

MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceu...
Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors | Benzinga

Poster highlights durable disease stabilization lasting beyond treatment completion Results suggest a unique, multimodal mechanism of action that...

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting | Benzinga

First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase ...

Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders | Benzinga

MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmace...
Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | Benzinga

MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmace...

Theratechnologies Appoints Elina Tea to its Board of Directors | Benzinga

MONTREAL, April 05, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmace...

Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform | Benzinga

Study to assess new camptothecin-peptide conjugates for the treatment of sortilin-positive colorectal cancers Separate data to highlight activi...
Theratechnologies Appoints Jordan Zwick to its Board of Directors | Benzinga

MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmace...

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau | Benzinga

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceu...

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance | Benzinga

Positive Adjusted EBITDA* for Q4 2023 more than doubles from Q3 2023 to $5 million (Net Loss of $2.8 million) leading to a significant tu...
Next 10